Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H18NO4.Cl.2H2O |
| Molecular Weight | 407.845 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.[Cl-].COC1=C(OC)C2=C(C=C1)C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=C2
InChI
InChIKey=NWMNHQUPWGJEKI-UHFFFAOYSA-M
InChI=1S/C20H18NO4.ClH.2H2O/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;;;/h3-4,7-10H,5-6,11H2,1-2H3;1H;2*1H2/q+1;;;/p-1
| Molecular Formula | C20H18NO4 |
| Molecular Weight | 336.3612 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://examine.com/supplements/berberine/ | https://www.ncbi.nlm.nih.gov/pubmed/19686830 | https://www.ncbi.nlm.nih.gov/pubmed/25610485
Curator's Comment: description was created based on several sources, including:
https://examine.com/supplements/berberine/ | https://www.ncbi.nlm.nih.gov/pubmed/19686830 | https://www.ncbi.nlm.nih.gov/pubmed/25610485
Berberine, an alkaloid isolated from Rhizoma Coptidis, is known to have a wide array of therapeutic effects including antimicrobial, antineoplastic, and hepatoprotective effects. It is found in several plants including European barberry, goldenseal, goldthread, Oregon grape, phellodendron, and tree tumeric. Berberine seems to slightly reduce blood sugar levels in people with diabetes. Berberine might lower blood pressure. Berberine is possibly safe for most adults for short-term use when taken by mouth or applied to the skin.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Screening for new compounds with antiherpes activity. | 1984 Oct |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991 Jan-Feb |
|
| Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. | 1997 Jul |
|
| [Determination of berberine in human serum by reversed-phase high performance liquid chromatography]. | 1997 Sep |
|
| Screening of compounds for antimicrosporidial activity in vitro. | 1998 |
|
| The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. | 1998 Dec |
|
| Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. | 1998 Oct |
|
| Analysis of coptisine, berberine and palmatine in adulterated Chinese medicine by capillary electrophoresis-electrospray ion trap mass spectrometry. | 2000 Jan 14 |
|
| [Inhibitory action of berberine on glucose absorption]. | 2003 Dec |
|
| [The interaction of berberine and human serum albumin]. | 2004 Jan |
|
| Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. | 2005 Nov |
|
| Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. | 2005 Winter |
|
| Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. | 2006 |
|
| Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. | 2006 Feb |
|
| Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. | 2008 Feb 25 |
|
| Effect of berberine on expression of hepatocyte nuclear factor-4alpha in rats with fructose-induced insulin resistance. | 2008 Jun |
|
| Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. | 2008 Nov 5 |
|
| Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. | 2010 Apr |
|
| Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. | 2010 Dec |
|
| Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells. | 2010 Dec |
|
| [Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary]. | 2010 Feb |
|
| Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. | 2010 Sep |
|
| Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat. | 2011 Apr |
|
| Berberine down-regulates the Th1/Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive manner. | 2011 Dec |
|
| Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. | 2011 Mar |
|
| Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. | 2011 Nov |
|
| Mechanism study of goldenseal-associated DNA damage. | 2013 Jul 31 |
|
| Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study. | 2013 May 23 |
|
| Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. | 2013 Nov 1 |
|
| Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice. | 2014 Dec |
|
| The potential effect of berberine in mercury-induced hepatorenal toxicity in albino rats. | 2014 Jul |
|
| Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes. | 2014 Jun |
|
| Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line. | 2014 Nov 5 |
|
| The neuroprotective effect of berberine in mercury-induced neurotoxicity in rats. | 2015 Aug |
|
| Kinetics and molecular docking studies of cholinesterase inhibitors derived from water layer of Lycopodiella cernua (L.) Pic. Serm. (II). | 2015 Oct 5 |
|
| Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. | 2016 Jan 5 |
Sample Use Guides
500 mg of berberine 2-3 times daily for up to 3 months
Route of Administration:
Oral
Berberine acted cytotoxically on both tumour cell lines. The melanoma B16 cells were much more sensitive to berberine treatment than the U937 cells. The value of IC(100) was below 100 ug/ml for the U937 cells and below 1 ug/ml for the B16 cells. As for both cell lines under the long-term influence the values of IC(50) were found to be less than 4 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:07:38 GMT 2023
by
admin
on
Sat Dec 16 01:07:38 GMT 2023
|
| Record UNII |
266464AEJZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB35498
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
100000124360
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
266464AEJZ
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
5956-60-5
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
160800
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
DTXSID5030820
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
SUB32396
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | |||
|
m2426
Created by
admin on Sat Dec 16 01:07:38 GMT 2023 , Edited by admin on Sat Dec 16 01:07:38 GMT 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |